US2013345300A1PendingUtilityA1

Small molecule modulators of the cold and menthol receptor trpm8

Assignee: KROHN MICHAELPriority: Mar 8, 2011Filed: Mar 8, 2012Published: Dec 26, 2013
Est. expiryMar 8, 2031(~4.6 yrs left)· nominal 20-yr term from priority
C07D 311/36A23V 2002/00A61K 31/353A61Q 19/00A61Q 17/02A61Q 11/00A61Q 5/00A61K 2800/782A61K 2800/244A61K 31/513A61K 31/496A61K 31/4439A61K 31/351A61K 31/137A61K 31/136A61K 31/00A61K 8/498A61K 8/4933A61K 8/49A61K 8/411A61K 8/41A23L 27/2056A23L 27/2054A23L 27/2052A23L 27/204A23L 27/88A61K 31/35Y10T428/249921A61K 31/352
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of compounds which are capable of producing a cooling sensation when they are brought into contact with the human body. In particular, the present invention relates to the use of compounds modulating TRPM8, and optionally to the use of compounds selectively exhibiting agonist activity at the TRPM8 channel. Such compounds have applications in many fields, particularly in oral and personal hygiene products and foodstuffs, but also in pharmaceutical composition products, cosmetics, textile products and packaging products. The present invention further relates to products containing such compounds and to the medical use of such compounds.

Claims

exact text as granted — not AI-modified
1 . A product comprising a Compound I.2 having the following general formula: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable derivative thereof; 
         wherein:
 R 1  is selected from —H; —OT 3 , —ST 3 , or —(C 1 -C 3 )alkyl, wherein T 3  is selected from —H or —(C 1 -C 2 )alkyl; 
 R 3  is selected from -phenyl or -heteroaryl selected from the group consisting of pyridine, pyrazine, pyridazine and pyrimidine, each of which is unsubstituted or substituted with 1 or 2 independently selected R 6  groups; 
 R 4  is selected from —(C 1 -C 3 )alkyl, —(C 2 -C 3 )alkenyl, —(C 2 -C 3 )alkynyl, or —(C 1 -C 3 )alkoxy; and 
 R 6  is selected from —H, —(C 1 -C 2 )alkyl, —(C 2 )alkenyl, —(C 2 )alkynyl, —OR 7 , —SR 7 , —C(halo) 3 , —CH(halo) 2 , —CH 2 (halo), —CN, -halo, —N 3 , —NO 2 , —N(R 7 ) 2 , —N(R 7 )OH, —C(═O)R 7 , —C(═O)OR 7 , —S(═O)R 7 , or —S(═O) 2 R 7 ; 
 each R 7  is independently selected from —H, or —CH 3 ; and 
 each halo is independently selected from —F, —Cl, —Br, or —I; 
 
         and wherein the product is selected from the group consisting of a cosmetic product composition, a food product composition, a textile product, a pharmaceutical product composition and a packaging product. 
       
     
     
         2 . The product of  claim 1 , wherein the compound exhibits selective agonist activity at TRPM8. 
     
     
         3 . The product of  claim 1 , wherein the compound exhibits activity at TRPM8, which activity is at least three times, or even at least four times, greater than the activity of the compound at TRPA1. 
     
     
         4 . The product of  claim 3 , wherein in a functional cell based assay the compound modulates the intracellular calcium level of human cells recombinantly expressing human TRPM8 at least four times more efficient than that of human cells recombinantly expressing human TRPA1. 
     
     
         5 . (canceled) 
     
     
         6 . The product of  claim 1 , wherein the compound is Compound I.3 having the following chemical structure: 
       
         
           
           
               
               
           
         
       
     
     
         7 . (canceled) 
     
     
         8 . The product of  claim 1 , wherein the cosmetic product composition is selected from the group consisting of an insect repellent composition, an oral hygiene composition, a skin care composition, and a hair care composition or the food product composition is selected from the group consisting of ice cream, mousse, crème, beverages and confectionery or the textile product is selected from the group consisting of shirts, trousers, socks, towels, headgear, underwear and shoes or the pharmaceutical product composition is selected from the group consisting of anticancer medicaments, bladder disease medicaments and medicaments for the treatment of pain. 
     
     
         9 - 11 . (canceled) 
     
     
         12 . A method of treating a patient comprising administering a compound as defined in  claim 1  to a patient in need thereof. 
     
     
         13 . A method of treating pain comprising administering a compound as defined in  claim 1  to a patient in need thereof. 
     
     
         14 . A method of producing a cooling sensation, the method comprising contacting skin and/or a mucosal membrane of a human or animal with an effective amount of a compound as defined in  claim 1  to produce the cooling sensation. 
     
     
         15 . In vitro method of modulating the cold and menthol receptor TRPM8, wherein TRPM8 is contacted with a compound as defined in  claim 1 . 
     
     
         16 . The product of  claim 5 , wherein the cosmetic product composition is selected from the group consisting of an insect repellent composition, an oral hygiene composition, a skin care composition, and a hair care composition or the food product composition is selected from the group consisting of ice cream, mousse, crème, beverages and confectionery or the textile product is selected from the group consisting of shirts, trousers, socks, towels, headgear, underwear and shoes or the pharmaceutical product composition is selected from the group consisting of anticancer medicaments, bladder disease medicaments and medicaments for the treatment of pain. 
     
     
         17 . A method of treating a patient comprising administering a compound as defined in  claim 5  to a patient in need thereof. 
     
     
         18 . A method of treating pain comprising administering a compound as defined in  claim 5  to a patient in need thereof. 
     
     
         19 . A method of producing a cooling sensation, the method comprising contacting skin and/or a mucosal membrane of a human or animal with an effective amount of a compound as defined in  claim 5  to produce the cooling sensation. 
     
     
         20 . In vitro method of modulating the cold and menthol receptor TRPM8, wherein TRPM8 is contacted with a compound as defined in  claim 5 .

Join the waitlist — get patent alerts

Track US2013345300A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.